News
10-07-2024, 10:47 AM
CDK12 is established as a tumor suppressor in prostate cancer, with its loss driving aggressive disease and creating vulnerabilities for targeted therapies.
More... (https://www.news-medical.net/news/20241007/When-CDK1213-stalls-healthy-prostate-cells-take-a-malignant-turn.aspx)
More... (https://www.news-medical.net/news/20241007/When-CDK1213-stalls-healthy-prostate-cells-take-a-malignant-turn.aspx)